… CANCER'S IP information, this Article answers these questions through a synthesis of
intellectual property and information policy-here, cancer's IP.Cancer's special salience to …

… , colon or prostate cancer. Statistical analyses verified that the relative risk of cancer incidence
in lung, … Despite the fact that these are major cancers in the US population, they could be …

… disappeared in vivo, where their cancer chemopreventive efficacies were found to be very
… selenium metabolite is important for cancer chemoprevention. Methylseleninic acid could be …

… In 15 colon specimens obtained from patients with diverticulitis but without cancer, IP reaction
was negative (Fig. 2). The control lgG-1 antibodies either did not react with tl"ese tissues …

… be involved in cancer protection. Unlike the stimulatory effect of linoleic acid in carcinogenesis
(Cancer Res., Ip et al., 45: 1997–2001, 1985), the reaction of CLA in cancer prevention is …

Conjugated linoleic acid (CLA) is a potent cancer preventive agent in animal models. To
date, all of the in vivo work with CLA has been done with a commercial free fatty acid …

… , which could lead to peak IP being present in earlier decades. … between peak IP and survival
after primary cancer diagnosis. … IP% of brain metastases by SEER stage of primary cancer …

Conjugated linoleic acid (CLA) is a collective term which refers to a mixture of positional and
geometric isomers of linoleic acid. It is naturally occurring in meat and dairy products. We …

Previously, α-tocopheryl succinate (α-TOS) has been reported to induce caspase-mediated
apoptosis in PC-3 human prostate cancer cells. Caspase-9 was among several initiator …

… the previously reported survival benefit observed with IP in Japanese patients. Both regimens
… IP. These results emphasize the potential importance of PG in interpreting trials of cancer …